This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Hao-Jui Weng: Innovator in Tmem100 Peptides
Introduction
Hao-Jui Weng is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic peptides.
Latest Patents
Weng holds a patent for "Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions." This invention features compositions of Tmem100 peptides and their variants, focusing on their application in treating or preventing various diseases.
Career Highlights
Hao-Jui Weng is affiliated with The Johns Hopkins University, where he engages in cutting-edge research. His work has implications for advancing medical treatments and improving patient outcomes.
Collaborations
Weng collaborates with Xinzhong Dong, contributing to innovative research efforts in their field.
Conclusion
Hao-Jui Weng's work on Tmem100 peptides exemplifies the impact of innovative research in medicine. His contributions are paving the way for new therapeutic approaches.